Ardelyx Inc (ARDX)
Healthcare
Biotechnology
5.00 $
-1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Ardelyx Inc (ARDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -42 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | -72 | -93 | -65 | -70 | -76 | -81 | -153 | -70 | -90 | -45 | -42 | |
| 0.3 | 0.8 | 1.3 | 2.6 | 2.7 | 2.5 | 1.8 | 1.4 | 1.1 | 1.3 | 2.1 | 3.1 | |
| 1.7 | 2.6 | 5.3 | 9.6 | 9.2 | 9.9 | 11 | 12 | 11 | 14 | 37 | 49 | |
| 3.3 | 2.7 | 5.3 | 9.6 | 9.6 | 11 | 11 | 15 | 10 | – | – | – | |
| 13 | -46 | 13 | -14 | 9.4 | 3.0 | -3.2 | -12 | -20 | -43 | -49 | -31 | |
| 1.9 | 3.5 | 4.9 | 2.4 | 0.3 | 0.3 | 0.3 | 1.9 | 0.1 | 0.3 | 1.0 | 1.5 | |
| -1.9 | -3.5 | -131 | 65 | -30 | 23 | -31 | 51 | 18 | -131 | -18 | -9.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | 0.1 | – | 26 | – | – | |
| 0.0 | 75 | 191 | 0.7 | 54 | 155 | 23 | -0.1 | 72 | 1.2 | 8.1 | – | |
| – | 49 | 49 | 49 | 49 | -0.1 | -0.1 | -19 | -6.1 | 22 | 99 | 49 | |
| 61 | 75 | 191 | 0.7 | 104 | 155 | 23 | 83 | 75 | 146 | 107 | 55 | |
| 73 | -0.3 | -32 | 0.8 | 3.4 | 102 | -90 | -19 | 24 | -75 | 43 | 3.1 | |
| 12 | -75 | -97 | -68 | -71 | -77 | -82 | -154 | -70 | -90 | -46 | -44 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.